Back to Avoro Capital Advisors LLC Avoro Capital Advisors LLC

MLTXMLTX
Showing 6 of 11 quarters

Position history for Avoro Capital Advisors LLCAvoro Capital Advisors LLC's holdings in MoonLake Immunotherapeutics Class A

Avoro Capital Advisors LLC previously held 0 shares of MLTX (MoonLake Immunotherapeutics Class A), worth $0 as of 2025-Q4.

Final Value

$0

Final Shares

0

Total Value Change

-$139.7M

Total Shares Change

-2.8M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q4
Latest
Exited
0
-100.0%
$00.0%$13.21
0
2025-Q3
Decreased
2M
-51.8%
$14.3M0.2%$6.24
0
2025-Q2
Increased
4.2M
+49.8%
$195.9M3.4%$47.52
79
2025-Q1
Unchanged
2.8M
0.0%
$108.2M1.7%$39.86
0
2024-Q4
Unchanged
2.8M
0.0%
$150M2.1%$53.02
0
2024-Q3
Increased
2.8M
0.0%
$139.7M2.0%$49.40
53

Other major holders of MLTX: FMR LLC, PRICE T ROWE ASSOCIATES INC /MD/

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used